Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (25)

Advertisement

Research Article Free access | 10.1172/JCI105607

Pathways of Ammonia Metabolism in the Intact Functioning Kidney of the Dog

William J. Stone and Robert F. Pitts

Department of Physiology, Cornell University Medical College, New York, N. Y.

†

Fellow of the New York Heart Association.

‡

Address requests for reprints to Dr. Robert F. Pitts, Dept. of Physiology,, Cornell University Medical College, 1300 York Ave., New York, N. Y. 10021.

*

Submitted for publication January 23, 1967; accepted March 15, 1967.

Aided by grants from the National Heart Institute of the National Institutes of Health (HE 00814, HTS 5264) and the Life Insurance Medical Research Fund.

Find articles by Stone, W. in: PubMed | Google Scholar

Department of Physiology, Cornell University Medical College, New York, N. Y.

†

Fellow of the New York Heart Association.

‡

Address requests for reprints to Dr. Robert F. Pitts, Dept. of Physiology,, Cornell University Medical College, 1300 York Ave., New York, N. Y. 10021.

*

Submitted for publication January 23, 1967; accepted March 15, 1967.

Aided by grants from the National Heart Institute of the National Institutes of Health (HE 00814, HTS 5264) and the Life Insurance Medical Research Fund.

Find articles by Pitts, R. in: PubMed | Google Scholar

Published July 1, 1967 - More info

Published in Volume 46, Issue 7 on July 1, 1967
J Clin Invest. 1967;46(7):1141–1150. https://doi.org/10.1172/JCI105607.
© 1967 The American Society for Clinical Investigation
Published July 1, 1967 - Version history
View PDF
Abstract

Studies in which 15N-labeled precursors of urinary ammonia were infused into the artery of an intact functioning kidney of an acidotic dog have led to the following conclusions: Preformed ammonia and ammonia derived from the amide nitrogen of plasma glutamine are added directly to urine without significant incorporation into amino acid intermediates of renal tissue. Thus, reductive amination of α-ketoglutarate to form glutamate does not occur to an appreciable extent nor is there significant transfer of the amide nitrogen of glutamine to the corresponding keto acids to form glutamate, aspartate, alanine, or glycine. The enzyme system “glutaminase II” may participate to a significant extent in the metabolism of glutamine by forming aspartate and alanine by direct transamination of oxalacetate and pyruvate and liberating the amide nitrogen as ammonia. Renal alanine exists as a well mixed pool derived in roughly equal amounts from filtered and reabsorbed plasma alanine and newly synthesized alanine. The alanine pool of tubular cells does not equilibrate with the alanine of peritubular capillary blood. Transfer of the nitrogen of alanine to α-ketoglutarate and subsequent oxidative demination of the resulting glutamate can account for the ammonia formed from alanine. Glycine is not an important intermediate in renal nitrogen metabolism.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1141
page 1141
icon of scanned page 1142
page 1142
icon of scanned page 1143
page 1143
icon of scanned page 1144
page 1144
icon of scanned page 1145
page 1145
icon of scanned page 1146
page 1146
icon of scanned page 1147
page 1147
icon of scanned page 1148
page 1148
icon of scanned page 1149
page 1149
icon of scanned page 1150
page 1150
Version history
  • Version 1 (July 1, 1967): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (25)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts